Beyond Air, Inc. (XAIR) stock: key figures, P/E, revenue and dividend

Health Care · United States · ISIN US08862L2025

Price
2.13 USD
Market cap
3.55 m USD
P/E (2026)
–
P/S (2026)
0.46
Dividend yield
0.00 %
Net margin
-432.99 %
Return on equity (ROE)
-542.75 %
Return on assets (ROA)
-93.96 %

Beyond Air, Inc. financials

Fiscal year20252026
Revenue3.71 m USD7.68 m USD
Gross profit-1.66 m USD252,000.00 USD
Operating income-44.54 m USD-29.04 m USD
EBIT-46.17 m USD-30.82 m USD
Net income-46.63 m USD-33.25 m USD
Diluted EPS – continuing operations-0.69 USD-4.01 USD

Full history since 2015, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Beyond Air, Inc.

Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company. It operates through Beyond Air, Beyond Cancer, and NeuroNos segments. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn. It is also developing LungFit PRO to treat viral lung infections, such as viral community-acquired pneumonia, including COVID-19 and bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria (NTM). In addition, the company develops ultra-high concentration NO (UNO) that is in Phase 1 clinical trial to treat solid tumors; and selective neuronal nitric oxide synthase (nNOS) inhibitor for the treatment of neurological conditions. It has a collaboration with the Yissum Research Development Company of the Hebrew University of Jerusalem, LTD to acquire the commercial rights for neuronal nitric oxide synthase inhibitors to treat autism spectrum disorder and other neurological conditions. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. was founded in 2011 and is headquartered in Garden City, New York.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.